Novo Nordisk, Eli Lilly rise after Viking obesity trial data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/3/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

Go back to Novo Nordisk, Eli Lilly rise after Viking obesity trial data
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1078.78 +14.63 (1.37%)
Previous Close $1064.15    52 Week High $88.16 
Open $1059.50    52 Week Low $67.88 
Day High $1093.28    P/E 249.72 
Day Low $1053.51    EPS $4.32 
Volume 2,653,763       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 42.00 -0.92 (2.14%)
Previous Close $42.92    52 Week High $59.00 
Open $42.72    52 Week Low $32.80 
Day High $42.77    P/E N/A 
Day Low $41.90    EPS $0.00 
Volume 11,327,543       

ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 29.33 +0.04 (0.14%)
Previous Close $29.29    52 Week High $5.17 
Open $29.39    52 Week Low $0.94 
Day High $29.80    P/E N/A 
Day Low $29.06    EPS $0.00 
Volume 1,467,640